Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Oh

Showing results (461-470 of 1,002) with videos related to

Pageof 101
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 1, 1994
Identification of insulin-like growth factor-binding protein-3 (IGFBP-3) fragments and IGFBP-5 proteolytic activity in human seminal plasma: a comparison of normal and vasectomized patientsK O Lee, Y Oh, L C Giudice, et al.
Pediatric Research|June 1, 1994
Insulin-like growth factor binding protein-3 concentrations and insulin-like growth factor binding protein-3 protease activity in sera of patients with malignant solid tumors or leukemiaH L Müller, Y Oh, S E Gargosky, et al.
Biochimica Et Biophysica Acta|October 17, 1998
Molecular characterization of the Drosophila melanogaster gene encoding the pterin 4alpha-carbinolamine dehydrataseC Seong, S Jeong, D Park, et al.
Oncoimmunology|December 15, 2018
Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancerKatsunobu Hagihara, Stephen Chan, Li Zhang, et al.
Neural Regeneration Research|August 30, 2020
Therapeutic potential of neuromodulation for demyelinating diseasesElliot H Choi, Chioma Nwakalor, Nolan J Brown, et al.
The Biochemical Journal|August 15, 1991
Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II moleculeY Oh, M W Beukers, H M Pham, et al.
Journal for Immunotherapy of Cancer|May 8, 2020
Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignanciesJason Cham, Li Zhang, Serena Kwek, et al.
Journal of Neuroendocrinology|September 13, 2006
Involvement of the ser-glu-pro motif in ligand species-dependent desensitisation of the rat gonadotrophin-releasing hormone receptorJ A Song, D Y Oh, J S Moon, et al.
American Journal of Preventive Medicine|May 21, 2017
Calibration and Validation of the Youth Activity Profile: The FLASHE StudyPedro F Saint-Maurice, Youngwon Kim, Paul Hibbing, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 5, 2009
Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cellsH-S Kim, W J Lee, S W Lee, et al.
Pageof 101

Showing results (461-470 of 1,002) with videos related to

Sort By:
Pageof 101
The Journal of Clinical Endocrinology and Metabolism|November 1, 1994
Identification of insulin-like growth factor-binding protein-3 (IGFBP-3) fragments and IGFBP-5 proteolytic activity in human seminal plasma: a comparison of normal and vasectomized patientsK O Lee, Y Oh, L C Giudice, et al.
Pediatric Research|June 1, 1994
Insulin-like growth factor binding protein-3 concentrations and insulin-like growth factor binding protein-3 protease activity in sera of patients with malignant solid tumors or leukemiaH L Müller, Y Oh, S E Gargosky, et al.
Biochimica Et Biophysica Acta|October 17, 1998
Molecular characterization of the Drosophila melanogaster gene encoding the pterin 4alpha-carbinolamine dehydrataseC Seong, S Jeong, D Park, et al.
Oncoimmunology|December 15, 2018
Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancerKatsunobu Hagihara, Stephen Chan, Li Zhang, et al.
Neural Regeneration Research|August 30, 2020
Therapeutic potential of neuromodulation for demyelinating diseasesElliot H Choi, Chioma Nwakalor, Nolan J Brown, et al.
The Biochemical Journal|August 15, 1991
Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II moleculeY Oh, M W Beukers, H M Pham, et al.
Journal for Immunotherapy of Cancer|May 8, 2020
Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignanciesJason Cham, Li Zhang, Serena Kwek, et al.
Journal of Neuroendocrinology|September 13, 2006
Involvement of the ser-glu-pro motif in ligand species-dependent desensitisation of the rat gonadotrophin-releasing hormone receptorJ A Song, D Y Oh, J S Moon, et al.
American Journal of Preventive Medicine|May 21, 2017
Calibration and Validation of the Youth Activity Profile: The FLASHE StudyPedro F Saint-Maurice, Youngwon Kim, Paul Hibbing, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 5, 2009
Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cellsH-S Kim, W J Lee, S W Lee, et al.
Pageof 101